Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,587,984 | 5,947,222 | 5,844,420 | 8,819,686 | 7,362,431 |
| Depreciation Amortization | 6,424,089 | 3,880,411 | 5,186,382 | 3,603,312 | 3,964,568 |
| Income taxes - deferred | -2,759,485 | -867,844 | -1,049,831 | -608,981 | -421,184 |
| Accounts receivable | -1,359,943 | -30,299 | -429,673 | -818,647 | 218,874 |
| Accounts payable and accrued liabilities | 450,297 | 853,777 | 435,085 | 476,227 | 533,578 |
| Other Working Capital | 1,917,723 | -665,492 | 826,877 | -449,887 | 1,599,551 |
| Other Operating Activity | 1,901,885 | 708,775 | 288,970 | 68,480 | -809,238 |
| Operating Cash Flow | $12,162,550 | $9,826,550 | $11,102,230 | $11,090,190 | $12,448,580 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -80,451 |
| PPE Investments | -3,044,598 | -1,876,361 | -2,174,341 | -751,217 | -1,567,607 |
| Net Acquisitions | 11,768,820 | -117,949 | N/A | N/A | N/A |
| Purchase Of Investment | -11,402,250 | -2,731,220 | -4,333,529 | -1,559,328 | -6,986,206 |
| Sale Of Investment | N/A | N/A | 45,457 | 141,182 | N/A |
| Other Investing Activity | -90,508 | -43,285 | -247,847 | -16,858 | 0 |
| Investing Cash Flow | $-2,768,536 | $-4,768,815 | $-6,710,260 | $-2,186,220 | $-8,634,264 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,244,540 | 63,844 | 827,960 | 226,524 | -489,803 |
| Debt Issued | 6,289,453 | N/A | 51,950 | 1,632,026 | N/A |
| Debt Repayment | -2,966,531 | -726,089 | -3,987,193 | -2,863,685 | -2,651,327 |
| Common Stock Issued | 200,258 | 202,353 | 211,049 | 198,077 | 220,057 |
| Common Stock Repurchased | -5,690,942 | -326,794 | -641,804 | -523,639 | -451,944 |
| Dividend Paid | -5,442,034 | -5,131,318 | -4,886,584 | -4,495,711 | -4,798,653 |
| Other Financing Activity | -431,063 | -318,137 | -290,058 | -306,597 | -176,282 |
| Financing Cash Flow | $-9,285,399 | $-6,236,142 | $-8,714,680 | $-6,133,005 | $-8,347,953 |
| Exchange Rate Effect | -53,176 | -14,067 | -34,634 | 8,429 | 17,747 |
| Beginning Cash Position | 8,418,747 | 9,425,091 | 13,784,170 | 10,639,250 | 16,462,840 |
| End Cash Position | 8,663,130 | 8,051,906 | 9,426,833 | 13,418,650 | 11,946,940 |
| Net Cash Flow | $244,382 | $-1,373,185 | $-4,357,340 | $2,779,397 | $-4,515,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,162,550 | 9,826,550 | 11,102,230 | 11,090,190 | 12,448,580 |
| Capital Expenditure | -4,002,893 | -3,457,310 | -3,272,875 | -2,318,974 | -2,417,073 |
| Free Cash Flow | 8,159,657 | 6,369,240 | 7,829,355 | 8,771,216 | 10,031,507 |